See more : Qianhai Health Holdings Limited (0911.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Hero Technologies Inc. (HENC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hero Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- GME Group Holdings Limited (8188.HK) Income Statement Analysis – Financial Results
- Global Resource Energy, Inc. (GBEN) Income Statement Analysis – Financial Results
- Alps Industries Limited (ALPSINDUS.BO) Income Statement Analysis – Financial Results
- Dong-A Socio Holdings Co., Ltd. (000640.KS) Income Statement Analysis – Financial Results
- Global Energy Metals Corporation (GEMC.V) Income Statement Analysis – Financial Results
Hero Technologies Inc. (HENC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://herotechnologiesinc.com
About Hero Technologies Inc.
Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 1.53K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
Cost of Revenue | 1.98K | 72.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -1.98K | -71.16K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.64M | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | -4,666.30% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 505.00K | 1.17M | 5.78M | 74.37K | 0.00 | 0.00 | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 167.03K | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 620.00 | 0.00 | 0.00 | 117.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 881.73K | 0.00 | 0.00 | 0.00 |
SG&A | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 1.05M | 1.33M | 28.20K | 20.08K |
Other Expenses | 0.00 | 2.05K | 0.00 | 0.00 | 0.00 | 0.00 | 229.40K | 0.00 | 0.00 | 0.00 | 3.40K | 6.81K | 625.73K | 0.00 | 0.00 | 47.42K | 0.00 | 0.00 |
Operating Expenses | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
Cost & Expenses | 507.60K | 1.24M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
Interest Income | 183.00 | 46.96 | 58.90 | 53.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.28K | 0.00 | 0.00 |
Interest Expense | 60.41K | 46.96K | 58.90K | 53.75K | 52.35K | 52.86K | 50.38K | 8.20K | 6.10K | 44.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.38K | 0.00 | 0.00 |
Depreciation & Amortization | 1.98K | 2.05K | 5.78M | 87.82K | 161.14K | 52.52K | 225.38K | -1.23M | 345.99 | 746.67K | -298.79K | -40.09K | 0.00 | 8.75M | -898.26K | 47.42K | 0.00 | 0.00 |
EBITDA | -505.43K | -3.46M | -180.53K | -12.78M | 18.01K | -79.25K | 1.32K | -1.68M | 35.78K | 330.96K | -603.63K | -602.79K | -2.47M | -8.65M | -1.91M | -673.00K | -1.37M | -20.08K |
EBITDA Ratio | 0.00% | -226,757.77% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -282.02% | -1,503.44% | 0.00% | 0.00% | 0.00% | -1,814.01% | 0.00% | 0.00% |
Operating Income | -507.60K | -3.46M | -5.78M | -118.05K | -146.09K | -133.68K | -228.09K | -441.79K | 41.87K | -415.71K | -1.10M | -562.70K | -2.47M | -2.14M | -1.01M | -1.47M | -28.20K | -20.08K |
Operating Income Ratio | 0.00% | -226,892.07% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -221.75% | -1,403.44% | 0.00% | 0.00% | 0.00% | -2,495.52% | 0.00% | 0.00% |
Total Other Income/Expenses | -60.23K | -2.27M | -180.53K | -12.75M | 111.76K | 1.57K | 175.01K | -1.24M | 0.00 | 702.02K | 0.00 | 0.00 | 0.00 | -8.75M | 1.00 | 564.12K | -1.43M | 0.00 |
Income Before Tax | -567.83K | -3.51M | -5.96M | -12.87M | -34.34K | -132.11K | -53.08K | -1.68M | 35.78K | 286.31K | -603.63K | -522.60K | -2.47M | -10.89M | -282.52K | -1.51M | -28.20K | -20.08K |
Income Before Tax Ratio | 0.00% | -230,357.31% | -3,024,328.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -2.26M | 58.90K | -87.81 | -161.14K | -52.52K | 37.68K | 37.92K | -288.06K | 828.58K | -98.49K | 522.60K | 0.00 | -2.24M | -1.09M | 1.51M | 28.20K | 20.08K |
Net Income | -541.58K | -1.25M | -6.02M | -12.87M | -34.34K | -132.11K | -90.76K | -1.72M | 323.84K | -542.27K | -603.63K | -522.60K | -2.47M | -8.65M | 808.32K | -1.51M | -28.20K | -20.08K |
Net Income Ratio | 0.00% | -81,849.38% | -3,054,224.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
Weighted Avg Shares Out | 447.96M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
Weighted Avg Shares Out (Dil) | 447.59M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
Hero or Zero? 3 Speculative Cannabis Stocks to Make You Rich or Broke
Hero or Zero? 3 High-Risk AI Stocks That Could Make You Rich
Delivery Hero winds down in Germany, ceding ground to rival Just Eat Takeaway
Hero Technologies' Subsidiary Obtains Key State Approval for Full Adult and Medicinal Use Cannabis Licenses in Michigan
Germany's Delivery Hero not considering offer for British rival Deliveroo
Delivery Hero Buys Stake In Rival Deliveroo
Germany's Delivery Hero takes 5.09% stake in rival Deliveroo
Hero Technologies' Ties Cannabis Sustainability to Profitability
Hero Technologies' Cannabis Grow Plan Prioritizes Sustainability against Climate Change
Hero Technologies Explores Marketing Its Proprietary Cannabis Cultivation System through Greenhouse Builder
Source: https://incomestatements.info
Category: Stock Reports